Renninger Robert 4/A
4/A · Athira Pharma, Inc. · Filed Mar 12, 2025
Insider Transaction Report
Form 4/AAmended
Renninger Robert
CHIEF FINANCIAL OFFICER
Transactions
- Award
Stock Option (Right to Buy)
2025-03-03+73,350→ 73,350 totalExercise: $0.38Exp: 2035-03-02→ Common Stock (73,350 underlying)
Footnotes (1)
- [F1]One fourth (1/4th) of shares subject to the option shall be scheduled to vest on the one (1)-year anniversary of the grant date, and one thirty-sixth (1/36th) of the remaining Shares subject to the Option each month thereafter on the same day of the month as the grant date subject to the optionee continuing to be a Service Provider (as defined in the Issuer's 2020 Equity Incentive Plan) through the applicable vesting dates.